Table 2.
Overview of the studies describing overall survival specified for resection with curative intent or palliative treatment
| Author (year) | Total study population | Resection with curative intent | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| No. of patients | Median survival (months) | 5-year survival (%) | No of patients (%) | Age (SD)a | Males (%) | Stage 0 | Stage I | Stage II | Stage III | Stage IV | Unknown | Median survival (months) | 5-year survival (%) | |
| Bakaeen31 | 101 | – | 37 | 68 (67) | – | – | 2 | 17 | 25 | 22 | 2 | 0 | – | 54 |
| Bhatti47 | 12 | 18 | 21 | 12 (100) | 55 (10) | 8 (67) | 4 | 3 | 5 | 0 | 18 | 21 | ||
| Buchbjerg2 | 71 | 8 | 11 | 28 (39) | – | – | 2 | 11 | 13 | 2 | 0 | 23 | 27 | |
| Cecchini32 | 169 | – | – | 103 (61) | – | – | 103 | 44 | 42 | |||||
| Han10 | 32 | – | 21 | 22 (69) | – | – | 22 | – | 32 | |||||
| Hung33 | 23 | 6 | 8 | 11 (48) | 64 (13) | 7 (64) | 4 | 3 | 3 | 1 | 0 | 38 | 17 | |
| Hurtuk44 | 52 | – | – | 35 (67) | – | – | 35 | 34 | – | |||||
| Jiang34 | 187b | – | – | 128 (68) | – | – | 128 | 57 | 44 | |||||
| Kaklamanos12 | 63 | 18 | 23 | 37 (59) | – | – | 8 | 11 | 18 | 0 | 31 | 37 | ||
| Kawahira35 | 21 | – | 39 | 12 (57) | – | – | 1 | 11 | 59 | 66 | ||||
| Kelsey22 | 32 | – | 48 | 32 (100) | 57 (11) | 23 (72) | 3 | 18 | 9 | 1 | 1 | – | 48 | |
| Kim45 | 24 | – | 39 | 24 (100) | 58 (11) | 14 (58) | 2 | 10 | 12 | 0 | – | 39 | ||
| Kim36 | 50 | 24 | 32 | 36 (72) | – | – | 7 | 16 | 13 | 0 | – | 47 | ||
| Lee37 | 53 | – | 29 | 28 (53) | – | – | 3 | 7 | 18 | 0 | – | 44 | ||
| Lee38 | 70 | – | – | 41 (59) | – | – | 2 | 21 | 18 | 0 | 25 | 61 | ||
| Liang41 | 36 | 21 | – | 36 (100) | 64 (13) | 24 (67) | 4 | 6 | 26 | 0 | 21 | – | ||
| Malleo40 | 37 | 70 | 59 | 25 (68) | 57 (11) | 14 (56) | 5 | 6 | 11 | 3 | 0 | 70 | 71 | |
| Onkendi11 | 124 | – | 37 | 99 (80) | – | – | 99 | 38 | 43 | |||||
| Poultsides42 | 122 | – | 48 | 122 (100) | 67 (14) | 66 (54) | 10 | 28 | 71 | 7 | 6 | – | 48 | |
| Sarela46 | 137 | – | – | 72 (53) | 62 (13) | 38 (53) | 72 | – | 71 | |||||
| Solaini24 | 178 | 44 | 43 | 150 (84) | – | – | 150 | 84 | 51 | |||||
| Struck48 | 30 | – | – | 30 (100) | 61 (10) | 22 (73) | 2 | 3 | 9 | 16 | 0 | 28 | 53 | |
| Swartz49 | 14 | 41 | 44 | 14 (100) | 53 (9) | 10 (71) | 14 | 0 | 41 | 44 | ||||
| Tocchi39 | 47 | – | – | 25 (53) | – | – | 25 | 38 | 51 | |||||
| All studies | 1685 | 31d | 36d | 1190 (71) | 4 | 74 | 174 | 269 | 17 | 652 | 49d | 48d | ||
| Author (year) | Palliative treatment | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| No of patients (%) | Age (SD)a | Males (%) | Stage II | Stage III | Stage IV | Unknown | Median survival (months) | 5-year survival (%) | |
| Bakaeen31 | 33 (33) | – | – | 33 | – | 0 | |||
| Bhatti47 | |||||||||
| Buchbjerg2 | 43 (61) | – | – | 43 | 5 | 0 | |||
| Cecchini32 | 66 (39) | – | – | 66 | 9 | 0 | |||
| Han10 | 10 (31) | – | – | 10 | – | 0 | |||
| Hung33 | 12c (52) | 73 (8) | 8 (67) | 1 | 1 | 10 | 0 | 2 | 0 |
| Hurtuk44 | 17 (33) | – | – | 17 | – | 0 | |||
| Jiang34 | 59 (32) | – | – | 59 | 7 | 0 | |||
| Kaklamanos12 | 26 (41) | – | – | 10 | 5 | 11 | 12 | 0 | |
| Kawahira35 | 9 (43) | – | – | 9 | 0 | 9 | 0 | ||
| Kelsey22 | |||||||||
| Kim45 | |||||||||
| Kim36 | 14 (28) | – | – | 5 | 8 | 1 | – | 0 | |
| Lee37 | 25 (47) | – | – | 25 | 8 | 0 | |||
| Lee38 | 29 (41) | – | – | 29 | 7 | 0 | |||
| Liang41 | |||||||||
| Malleo40 | 12 (32) | – | 7 (58) | 1 | 5 | 6 | 0 | – | – |
| Onkendi11 | 25 (20) | – | – | 25 | 6 | 15 | |||
| Poultsides42 | |||||||||
| Sarela46 | 65 (47) | – | 37 (57) | 65 | – | – | |||
| Solaini24 | 28 (16) | – | – | 28 | 8 | 0 | |||
| Struck48 | |||||||||
| Swartz49 | |||||||||
| Tocchi39 | 22 (47) | – | – | 22 | 9 | 0 | |||
| All studies | 495 (29) | 2 | 21 | 38 | 434 | 8d | 1d | ||
aAge: mean in years (range in years)
bLong-term analysis
cPalliative treatment and supportive therapy
dWeighted mean of median survival and 5-year survival of all studies
– Indicates not reported